EHAMIA
REGN icon

EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Regeneron Pharmaceuticals REGN Stock Holding History

EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-347
Closed -$205K – 107
2022
Q2 		$205K Hold
347
– – 0.32% 98
2022
Q1 		$242K Buy
+347
New +$220K 0.31% 92

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAGLE HARBOR ASSET MANAGEMENT INC /ADV's REGN Position: Q3 2022 in Review

EAGLE HARBOR ASSET MANAGEMENT INC /ADV sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 347 shares — an estimated $205K sold.

EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in REGN in Q1 2022 and held it in 2 quarters. The position peaked at $242K in Q1 2022. 1,081 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV sold 347 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $205K.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in Regeneron Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV's Regeneron Pharmaceuticals position peaked at $242K in Q1 2022.
  • 1,081 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on EAGLE HARBOR ASSET MANAGEMENT INC /ADV's 13F filing for Q3 2022, filed 11 Aug 2026.